Coeptis Therapeutics (COEP)

• Market cap: $78.5M
• 1 day: -3.61%
• 5 days: 1.8%
• 1 month: -4.55%
• 3 months: -9.87%
• 6 months: 77.54%
• Year to date: 0.41%
• 1 year: 110.3%
• 5 years: -92.82%
• 10 years: -92.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Employees: 7